NR4A1 and breast cancer: However, to date, none of these markers are used in clinical practice.<h4>Methods</h4>We conducted a systematic review of PubMed and EMBASE to assess the number and level of evidence of published DNA methylation markers for hormone receptor-positive breast cancer.